Search

Your search keyword '"Ginanneschi, U"' showing total 24 results
Start Over Author "Ginanneschi, U" Database OpenAIRE
24 results on '"Ginanneschi, U"'

9. STENOSI DEL COLON DA PANCREATITE RECIDIVANTE

Author

Ginanneschi, U, Sasso, F, Ressetta, Giancarlo, Milone, E, Forlivesi, F., Ginanneschi, U, Sasso, F, Ressetta, Giancarlo, Milone, E, and Forlivesi, F.

Published
1980

10. Situazioni di urgenza nella patologia del colon sinistro: validità della fibrosigmoidoscopia nella diagnosi differenziale

Author

GABRIELLI, FRANCESCO, Ginanneschi, U, Fazio, FM, Gabrielli, F, Ginanneschi, U, and Fazio, F

Subjects
Situazioni di urgenza nella patologia del colon sinistro
Abstract

The Authors, although not working in an emergency ward, have performed 30 fiberoptic sigmoidoscopies (FFS) in emergencies on patients hospitalized in their Institutes. The indications for the investigation were: acute bowel obstruction (22 cases); severe post-operative diarrhea (5 cases); massive rectal bleeding (8 cases). In all the patients, FFS, performed immediately, allowed diagnosis of both the type and the site of tht lesion. The Authors believe that fiberoptic sigmoidoscopy, in trained hands, in emergencies can be a valid and safe tool for a quick and sure diagnosis. In particular, as far as acute intestinal obstruction is concerned, FFS can prove useful for the defferential diagnosis between mechanical and dynamic ileus; it is also clearly indicated in order to establish, during the pre-operative phase, the neoplastic or not-neoplastic character of the lesions. FFS should, therefore, be performed every time the clinical data and the direct radiography of the abdomen suggest a left colon obstruction

Published
1983

24. Relative survival in dilated cardiomyopathy: a stratification study of long-term outcome to evaluate life insurance cover

Author

Barbati, G., Merlo, M., Marocco, P., Dario Gregori, Sabbadini, G., Lattuada, L., Ginanneschi, U., Sinagra, G., Di Lenarda, A., Barbati, Giulia, Merlo, M., Marocco, P., Gregori, D., Sabbadini, Gastone, Lattuada, L., Ginanneschi, Ugo, Sinagra, Gianfranco, and Lenarda, A. D.

Subjects
Cardiomyopathy, Dilated, Age Factors, Cardiomyopathy, Dilated, epidemiology/mortality, Humans, Insurance, Life, Italy, epidemiology, Kaplan-Meier Estimate, Life Tables, Prognosis, Registries, Risk, Sex Factors, Time Factors, Treatment Outcome, epidemiology/mortality, Risk, Time Factors, Cardiomyopathy, Age Factors, Kaplan-Meier Estimate, Prognosis, Insurance, Insurance, Life, Sex Factors, Treatment Outcome, Life, Italy, Humans, epidemiology, Life Tables, Registries
Abstract

The aim of this study was to compare mortality of dilated cardiomyopathy (DCM) patients with the mortality in the background Italian population, taking into account demographic characteristics and clinical stratification of long-term outcome, ie, "reverse remodelling" within the first 2 years of follow-up.DCM is a myocardial disease, characterized by left and/or right ventricular dilation and dysfunction and poor outcome. Evidence-based treatment with ACE inhibitors, beta-blockers and, in the last decade, implantable cardioverter defibrillators have been demonstrated to improve significantly heart failure symptoms and prognosis. At present, DCM patients are unlikely to be accepted for life insurance.A cohort of 577 DCM patients consecutively enrolled from 1988 to 2004 in the Heart Muscle Disease Registry of Trieste, Italy, was matched by sex, age and registry data entry with the mortality data of the Italian population. Relative survival has been estimated by means of Kaplan-Meier technique, and mortality ratios (MR) with corresponding 95\% confidence intervals have been computed.DCM patients who showed a significant reverse remodelling within the first 2 years of treatment showed comparable survival with respect to the control population, and therefore could be taken into consideration for life insurance coverage, at least for a short or medium-term of years.The data illustrate that survival probability strongly depend on the individual treatment and evolution of the disease and could be easily measured within the first 2 years of follow-up. If this information is collected at the time of evaluation of an applicant for life cover, the insurance company could possibly improve its risk stratification.

Catalog

Books, media, physical & digital resources
See catalog results